{"filing":{"accession_number":"0001829126-26-010100","cik":"0001557376","ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","form":"8-K","filing_date":"2026-09-15","report_date":"2026-09-15","primary_document":"zeoscientifix_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912626010100/zeoscientifix_8k.htm"},"events":[{"id":33469,"run_id":30774,"accession_number":"0001829126-26-010100","anchor_item_number":"8.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.78,"summary":"ZEO ScientifiX announced a planned expansion into Georgia and Tennessee following enactment of new state laws establishing frameworks for stem cell and regenerative medicine therapies. This is a material operational and strategic business event—a geographic market expansion tied to new regulatory frameworks—that does not fit a specific named category. The expansion represents a significant growth initiative for the company's Southeast presence and business strategy, making it material to investors, but it is fundamentally an operational/strategic announcement rather than a financial transaction (M\u0026A), governance matter, or other specialized event type.","company_name":"Zeo ScientifiX, Inc.","ticker":"ZEOX","filing_date":"2026-09-15","form":"8-K","submitted_at":null,"items":[{"id":36922,"accession_number":"0001829126-26-010100","item_number":"8.01","item_title":"Other Events.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.78,"reasoning":"ZEO ScientifiX announced a planned expansion into Georgia and Tennessee following enactment of new state laws establishing frameworks for stem cell and regenerative medicine therapies. This is a material operational and strategic business event—a geographic market expansion tied to new regulatory frameworks—that does not fit a specific named category. The expansion represents a significant growth initiative for the company's Southeast presence and business strategy, making it material to investors, but it is fundamentally an operational/strategic announcement rather than a financial transaction (M\u0026A), governance matter, or other specialized event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-15T11:46:46.741963+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36922,"accession_number":"0001829126-26-010100","item_number":"8.01","item_title":"Other Events.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.78,"reasoning":"ZEO ScientifiX announced a planned expansion into Georgia and Tennessee following enactment of new state laws establishing frameworks for stem cell and regenerative medicine therapies. This is a material operational and strategic business event—a geographic market expansion tied to new regulatory frameworks—that does not fit a specific named category. The expansion represents a significant growth initiative for the company's Southeast presence and business strategy, making it material to investors, but it is fundamentally an operational/strategic announcement rather than a financial transaction (M\u0026A), governance matter, or other specialized event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-15T11:46:46.741963+00:00","company_name":"Zeo ScientifiX, Inc.","ticker":"ZEOX","filing_date":"2026-09-15"}]}